The mechanism of perturbation in monoamine metabolism by L-DOPA therapy: in vivo and in vitro studies
- 1 October 1992
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 90 (3) , 183-197
- https://doi.org/10.1007/bf01250960
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Allosteric effect of tetrahydrobiopterin cofactors on tyrosine hydroxylase activityLife Sciences, 1992
- Reduction of enzymatic activity of tyrosine hydroxylase by a heterocyclic amine, 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1), was due to reduced affinity to a cofactor biopterinNeuroscience Letters, 1991
- Reduction of enzyme activity of tyrosine hydroxylase and aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by carcinogenic heterocyclic aminesBiochemical and Biophysical Research Communications, 1988
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- 3‐O‐Methyldopa and the response to levodopa in Parkinson's diseaseAnnals of Neurology, 1987
- Purification and Kinetic Mechanism of Human Brain Soluble Catechol-O-MethyltransferaseJournal of Neurochemistry, 1985
- 3‐O‐ methyldopa blocks dopa metabolism in rat corpus striatumAnnals of Neurology, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975
- Effect of L-DOPA treatment on brain serotonin metabolism in depressed patientsLife Sciences, 1971